Semaglutide versus dulaglutide once weekly in patients with type 2 diabetes (SUSTAIN 7): a randomised, open-label, phase 3b trial
- Resource Type
- Article
- Source
- In
The Lancet Diabetes & Endocrinology April 2018 6(4):275-286 - Subject
Primary Research Articles - Language
- ISSN
- 2213-8587